Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.

R Dummer; M Beyer; K Hymes; MT Epping; R Bernards; M Steinhoff; W Sterry; Helmut Kerl; K Heath; JD Ahern; JS Hardwick; J Garcia-Vargas; K Baumann; S Rizvi; SR Frankel; SJ Whittaker; C Assaf

doi:10.3109/10428194.2012.656625

Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.

R Dummer
, M Beyer
, K Hymes
, MT Epping
, R Bernards
, M Steinhoff
, W Sterry
, Helmut Kerl
, K Heath
, JD Ahern
, JS Hardwick
, J Garcia-Vargas
, K Baumann
, S Rizvi
, SR Frankel
, SJ Whittaker
, C Assaf

Department of Dermatology and Venereology

Research output: Contribution to journal › Research article

56 Citations (Web of Science)

Original language	English
Journal	Leukemia and Lymphoma
DOIs	https://doi.org/10.3109/10428194.2012.656625
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

Research Fields

Cancer Research

DOI

10.3109/10428194.2012.656625

Links

Cite this

Dummer, R., Beyer, M., Hymes, K., Epping, MT., Bernards, R., Steinhoff, M., Sterry, W., Kerl, H., Heath, K., Ahern, JD., Hardwick, JS., Garcia-Vargas, J., Baumann, K., Rizvi, S., Frankel, SR., Whittaker, SJ., & Assaf, C. (2012). Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition. Leukemia and Lymphoma. https://doi.org/10.3109/10428194.2012.656625

@article{1e795a5519544bf3bfe7671fbf68b1a3,

title = "Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.",

author = "R Dummer and M Beyer and K Hymes and MT Epping and R Bernards and M Steinhoff and W Sterry and Helmut Kerl and K Heath and JD Ahern and JS Hardwick and J Garcia-Vargas and K Baumann and S Rizvi and SR Frankel and SJ Whittaker and C Assaf",

year = "2012",

doi = "10.3109/10428194.2012.656625",

language = "English",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

}

Dummer, R, Beyer, M, Hymes, K, Epping, MT, Bernards, R, Steinhoff, M, Sterry, W, Kerl, H, Heath, K, Ahern, JD, Hardwick, JS, Garcia-Vargas, J, Baumann, K, Rizvi, S, Frankel, SR, Whittaker, SJ & Assaf, C 2012, 'Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.', Leukemia and Lymphoma. https://doi.org/10.3109/10428194.2012.656625

TY - JOUR

T1 - Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.

AU - Dummer, R

AU - Beyer, M

AU - Hymes, K

AU - Epping, MT

AU - Bernards, R

AU - Steinhoff, M

AU - Sterry, W

AU - Kerl, Helmut

AU - Heath, K

AU - Ahern, JD

AU - Hardwick, JS

AU - Garcia-Vargas, J

AU - Baumann, K

AU - Rizvi, S

AU - Frankel, SR

AU - Whittaker, SJ

AU - Assaf, C

PY - 2012

Y1 - 2012

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000306566000014

UR - https://pubmed.ncbi.nlm.nih.gov/22239668

U2 - 10.3109/10428194.2012.656625

DO - 10.3109/10428194.2012.656625

M3 - Research article

C2 - 22239668

SN - 1042-8194

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

ER -